These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 23117849)
21. Risk Factors of Infection and Role of Antibiotic Prophylaxis in Totally Implantable Venous Access Port Placement: Propensity Score Matching. Nezami N; Xing M; Groenwald M; Silin D; Kokabi N; Latich I Cardiovasc Intervent Radiol; 2019 Sep; 42(9):1302-1310. PubMed ID: 31187229 [TBL] [Abstract][Full Text] [Related]
22. Septic transfusion reactions during blood transfusion via indwelling central venous catheters. Ricci KS; Martinez F; Lichtiger B; Han XY Transfusion; 2014 Oct; 54(10):2412-8. PubMed ID: 24725023 [TBL] [Abstract][Full Text] [Related]
23. A comparison of infections and complications in central venous catheters in adults with solid tumours. Coady K; Ali M; Sidloff D; Kenningham RR; Ahmed S J Vasc Access; 2015; 16(1):38-41. PubMed ID: 25198809 [TBL] [Abstract][Full Text] [Related]
24. Incidence of catheter-related bloodstream infections in neonates following removal of peripherally inserted central venous catheters. Casner M; Hoesli SJ; Slaughter JC; Hill M; Weitkamp JH Pediatr Crit Care Med; 2014 Jan; 15(1):42-8. PubMed ID: 24141656 [TBL] [Abstract][Full Text] [Related]
25. Clinical outcomes of totally implantable venous access port placement via the axillary vein in patients with head and neck malignancy. Hong S; Seo TS; Song MG; Seol HY; Suh SI; Ryoo IS J Vasc Access; 2019 Mar; 20(2):134-139. PubMed ID: 29923460 [TBL] [Abstract][Full Text] [Related]
26. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study. Dal Molin A; Rasero L; Guerretta L; Perfetti E; Clerico M Eur J Oncol Nurs; 2011 Dec; 15(5):377-81. PubMed ID: 21167777 [TBL] [Abstract][Full Text] [Related]
27. Risk factors of infection of totally implantable venous access port: A retrospective study. Guan X; Yan H; Zhang J; Li Y; Zhou Y J Vasc Access; 2023 Nov; 24(6):1340-1348. PubMed ID: 35389296 [TBL] [Abstract][Full Text] [Related]
28. Late complications of totally implantable venous access ports in patients with cancer: Risk factors and related nursing strategies. Yu XY; Xu JL; Li D; Jiang ZF Medicine (Baltimore); 2018 Sep; 97(38):e12427. PubMed ID: 30235721 [TBL] [Abstract][Full Text] [Related]
29. Totally implantable venous access ports: a prospective long-term study of early and late complications in adult patients with cancer. Voog E; Campion L; du Rusquec P; Bourgeois H; Domont J; Denis F; Emmanuel E; Dupuis O; Ganem G; Lafont C; Le Du K; Pavluc E; Pointreau Y; Roche S; Juhel-Voog L; Zinger M; Solal-Celigny P Support Care Cancer; 2018 Jan; 26(1):81-89. PubMed ID: 28756472 [TBL] [Abstract][Full Text] [Related]
30. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma]. Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328 [TBL] [Abstract][Full Text] [Related]
31. Incidence and risk factors of infectious complications related to implantable venous-access ports. Shim J; Seo TS; Song MG; Cha IH; Kim JS; Choi CW; Seo JH; Oh SC Korean J Radiol; 2014; 15(4):494-500. PubMed ID: 25053910 [TBL] [Abstract][Full Text] [Related]
33. Sepsis and septic shock - an observational study of the incidence, management, and mortality predictors in a medical intensive care unit. Vucelić V; Klobučar I; Đuras-Cuculić B; Gverić Grginić A; Prohaska-Potočnik C; Jajić I; Vučičević Ž; Degoricija V Croat Med J; 2020 Oct; 61(5):429-439. PubMed ID: 33150761 [TBL] [Abstract][Full Text] [Related]
34. Incidence and mortality of sepsis, severe sepsis, and septic shock in intensive care unit patients with candidemia. Ng K; Schorr C; Reboli AC; Zanotti S; Tsigrelis C Infect Dis (Lond); 2015 Aug; 47(8):584-7. PubMed ID: 25811137 [TBL] [Abstract][Full Text] [Related]
35. Incidence and risk factors for central venous access port-related infection in Chinese cancer patients. Wang TY; Lee KD; Chen PT; Chen MC; Chen YY; Huang CE; Kuan FC; Chen CC; Lu CH J Formos Med Assoc; 2015 Nov; 114(11):1055-60. PubMed ID: 26253646 [TBL] [Abstract][Full Text] [Related]
36. Survival in neutropenic patients with severe sepsis or septic shock. Legrand M; Max A; Peigne V; Mariotte E; Canet E; Debrumetz A; Lemiale V; Seguin A; Darmon M; Schlemmer B; Azoulay E Crit Care Med; 2012 Jan; 40(1):43-9. PubMed ID: 21926615 [TBL] [Abstract][Full Text] [Related]
37. Analysis of related complications of totally implantable venous access ports in children's chemotherapy: Single center experience. Zhang S; Xiao Z; Yang F Medicine (Baltimore); 2022 Jul; 101(27):e29899. PubMed ID: 35801731 [TBL] [Abstract][Full Text] [Related]
38. Peripherally inserted central catheter-related complications in cancer patients: a prospective study of over 50,000 catheter days. Kang J; Chen W; Sun W; Ge R; Li H; Ma E; Su Q; Cheng F; Hong J; Zhang Y; Lei C; Wang X; Jin A; Liu W J Vasc Access; 2017 Mar; 18(2):153-157. PubMed ID: 28218366 [TBL] [Abstract][Full Text] [Related]
39. Current etiology, clinical features and outcomes of bacteremia in older patients with solid tumors. Antonio M; Gudiol C; Royo-Cebrecos C; Grillo S; Ardanuy C; Carratalà J J Geriatr Oncol; 2019 Mar; 10(2):246-251. PubMed ID: 30005979 [TBL] [Abstract][Full Text] [Related]
40. Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study. SepNet Critical Care Trials Group Intensive Care Med; 2016 Dec; 42(12):1980-1989. PubMed ID: 27686355 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]